Telemedicine for reproductive medicine: pandemic and beyond
J Assist Reprod Genet
.
2022 Feb;39(2):327-329.
doi: 10.1007/s10815-021-02383-y.
Epub 2022 Jan 13.
Authors
Denis A Vaughan
#
1
2
3
4
,
Sophia H Yin
#
5
6
7
,
Jaimin S Shah
8
5
6
7
,
Annika Gompers
5
6
7
,
Michele R Hacker
5
6
7
,
Denny Sakkas
8
,
Alice Domar
8
5
6
7
,
Thomas L Toth
8
5
6
7
Affiliations
1
Boston IVF - The Eugin Group, 130 2nd Ave, Waltham, MA, 02451, USA. DVaughan@bidmc.harvard.edu.
2
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA. DVaughan@bidmc.harvard.edu.
3
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA. DVaughan@bidmc.harvard.edu.
4
Harvard Medical School, Boston, MA, USA. DVaughan@bidmc.harvard.edu.
5
Department of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
6
Department of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA.
7
Harvard Medical School, Boston, MA, USA.
8
Boston IVF - The Eugin Group, 130 2nd Ave, Waltham, MA, 02451, USA.
#
Contributed equally.
PMID:
35025052
PMCID:
PMC8756755
DOI:
10.1007/s10815-021-02383-y
No abstract available
Publication types
Letter
MeSH terms
Humans
Pandemics
Reproductive Medicine*
SARS-CoV-2
Telemedicine*
Grants and funding
UL1 TR002541/TR/NCATS NIH HHS/United States
National Institutes of Health Award UL1 TR002541/Foundation for the National Institutes of Health